Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02202746
Brief Title: A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

First Submitted : July 25, 2014
First Submitted that Met QC Criteria : July 25, 2014
First Posted : July 29, 2014 (Estimate)

Results First Submitted : February 20, 2020
Results First Submitted that Met QC Criteria : June 20, 2020
Results First Posted : June 23, 2020

Certification/Extension First Submitted : August 5, 2019
Certification/Extension First Submitted that Met QC Criteria : August 5, 2019
Certification/Extension First Posted : August 12, 2019

Last Update Submitted that Met QC Criteria : June 20, 2020
Last Update Posted : June 23, 2020